Concepedia

Scopolamine Use

Scopolamine Use is a pharmacological intervention involving the administration of scopolamine, an antimuscarinic agent, to modulate secretory activity in clinical contexts by selectively inhibiting parasympathetically mediated exocrine secretions.

884

Publications

34.4K

Citations

3.2K

Authors

1K

Institutions

Publications per year

2017–2026

127

Parents

Publications

884

Antidepressant Efficacy of the Antimuscarinic Drug Scopolamine

Maura L. Furey, Wayne C. Drevets · Archives of General Psychiatry · 2006 · 416 citations

, , +17

Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses

Bhavya Voleti, Andrea Navarria, Rong-Jian Liu et al. · Biological Psychiatry · 2013 · 262 citations · Full text

, , +16

Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementia

William W. Beatty, Nelson Butters, David S. Janowsky · Behavioral and Neural Biology · 1986 · 250 citations

, , +16

THE INCIDENCE AND ETIOLOGY OF POSTANESTHETIC EXCITEMENT A Clinical Survey

James E. Eckenhoff, Dorothy H. Kneale, Robert D. Dripps · Anesthesiology · 1961 · 249 citations · Full text

, , +16

Conditioning of food aversions by injections of psychoactive drugs.

Barry D. Berger · Journal of Comparative and Physiological Psychology · 1972 · 240 citations

, , +12

1–5 of 884

Authors

3.2K

  1. TS
    Trey Sunderland

    National Institute of Mental Health, United States

    8 publications · 264 citations

    8

    h-index

  2. CD
    Charles D. Wood

    Louisiana State University in Shreveport, United States

    7 publications · 217 citations

    7

    h-index

  3. PR
    Paavo Riekkinen

    University of Eastern Finland, Finland

    7 publications · 234 citations

    5

    h-index

  4. HW
    Herbert Weingartner

    National Institute of Mental Health, United States

    5 publications · 302 citations

    5

    h-index

  5. SM
    Susan Molchan

    National Institute of Mental Health, United States

    5 publications · 151 citations

    5

    h-index

1–5 of 3.2K

Institutions

1K

  1. Kyung Hee University

    Seoul, South Korea

    15 h-index

    66 publications

    2.9K citations

  2. National Institute of Mental Health

    Bethesda, United States

    12 h-index

    45 publications

    3K citations

  3. Seoul National University

    Seoul, South Korea

    12 h-index

    38 publications

    2.4K citations

  4. Harvard University

    Cambridge, United States

    11 h-index

    20 publications

    577 citations

  5. Kangwon National University

    Chuncheon, South Korea

    8 h-index

    33 publications

    868 citations

  6. National Institutes of Health

    Bethesda, United States

    7 h-index

    19 publications

    1.5K citations

  7. University of Eastern Finland

    Joensuu, Finland

    7 h-index

    22 publications

    674 citations

  8. University of Toronto

    Toronto, Canada

    7 h-index

    14 publications

    450 citations

1–8 of 1K

Venues

  1. Psychopharmacology

    55 publications · 2.6K citations

    30

    h-index

  2. PubMed

    Repository · 67 publications · 1.7K citations

    25

    h-index

  3. Pharmacology Biochemistry and Behavior

    38 publications · 1.6K citations

    25

    h-index

  4. 17

    h-index

  5. European Journal of Pharmacology

    EJP · 14 publications · 645 citations

    14

    h-index

1–5